Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SPP2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SPP2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SPP2 mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in decreased expression of SPP2 mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of SPP2 mRNA | increases expression | 17912697
|
D002104 |
Cadmium |
Cadmium results in increased expression of SPP2 mRNA | increases expression | 17327699
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of SPP2 mRNA | increases expression | 17327699
|
D002118 |
Calcium |
Calcium affects the expression of SPP2 mRNA | affects expression | 15913539
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SPP2 mRNA | decreases expression | 20106945
|
D003687 |
Dehydroepiandrosterone |
Dehydroepiandrosterone results in decreased expression of SPP2 mRNA | decreases expression | 17823450
|
D004958 |
Estradiol |
Estradiol results in decreased expression of SPP2 mRNA | decreases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPP2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of SPP2 mRNA | decreases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SPP2 mRNA | increases expression | 15644576
|
D014501 |
Uranium |
Uranium affects the expression of SPP2 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of SPP2 mRNA | affects expression | 15672453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.10 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000309 |
Adrenal Insufficiency |
|
Dehydroepiandrosterone |
5.78 | 17302879 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.87 | 10982225 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.64 | 15687053 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.87 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
1.97 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.97 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.97 | 17261762 16675129 17289903 12948864 14630087 19861407 18497071 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.48 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.54 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.54 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.54 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.01 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.23 | 16247446 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.58 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
11.28 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.28 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.28 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.76 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.76 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.76 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.78 | 16285004 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Dehydroepiandrosterone |
3.69 | 16616286 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.41 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.16 | 16177239 12705907 19923254 12153990 11287661 11529661 19420014 11739529 19739265 12540782 19164858 18713872 14986274 10663392 16081117 10915739 16109766 11743745 11421492 10774834 16227642 18071297 12392966 14550746 2444490 17906064 16485898 11461765 15619225 19370779 14725611 19416960 11834606 16393943 16781746 17522070 12594235 19085960 15968718 17562736 12958197 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.16 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.16 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.13 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 16714409 15322242 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.98 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.58 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.58 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.71 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 19772884 18467677 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.06 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.78 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 18606429 16354765 16959395 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.70 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.95 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.95 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.86 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
17.67 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
17.67 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
17.67 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
17.67 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
19.09 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
19.09 | 16962696 16226777 16322080 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
19.09 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
19.09 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
19.09 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.28 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.28 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.08 | 16316344 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.38 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.38 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 19784758 19460945 11587558 12969438 16610002 19014921 12587719 16611625 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.24 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.75 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Dehydroepiandrosterone |
10.75 | 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.75 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.99 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dehydroepiandrosterone |
9.99 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.99 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.49 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
3.49 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.49 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.06 | 14737004 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.16 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
10.23 | 15591091 19196722 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Dehydroepiandrosterone |
10.23 | 16457693 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.23 | 16891317 17203775 11807958 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.51 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.58 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.26 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.26 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.95 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.81 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.75 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
16.42 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
16.42 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.42 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.87 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.78 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Dehydroepiandrosterone |
5.03 | 16397352 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.01 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.22 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.39 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.40 | 15687053 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.58 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.58 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.57 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.57 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.12 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.12 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.81 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 16192470 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.00 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.72 | 19048282 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.98 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.04 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |